Astera Labs' revenue re-accelerated from $113.1M in Q3 2024 to $584.9M in Q3 2026, with 153.7% year-over-year growth in the latest quarter, and gross margins held between 72.3% and 77.9%, suggesting strong pricing power for its PCIe and CXL connectivity products.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue scaled roughly fivefold over ten quarters to $584.9M while gross margin held near 72-78% and operating margin expanded to 30.6% in Q3 2026, though R&D at $171.0M (about 29% of revenue) suggests the cost base is engineering-heavy.
Astera Labs is leading the transition to AI Infrastructure 2.0 with purpose-built silicon hardware and software solutions grounded in open standards.
The company doubled its revenue to $852.5 million in fiscal 2025, indicating robust financial performance and growth potential.
Astera specializes in designing high-speed connectivity solutions for data centers and AI, addressing a critical need in the industry.
Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 3, 2026 | $1.32+10.9% vs $1.19 | $585M+6.2% vs $551M |
Q3 2026 Aug 4, 2026 | $0.80+15.8% vs $0.69 | $392M+8.7% vs $361M |
Q2 2026 May 5, 2026 | $0.61+13.6% vs $0.54 | $308M+5.5% vs $292M |
Q1 2026 Feb 10, 2026 | $0.58+12.4% vs $0.52 | $271M+8.4% vs $250M |
I rate Astera Labs a Buy with a 12-month target price of $265.52, 18.9% above the recent close. ALAB has outperformed consensus revenue every quarter in FY26, yet the stock is down 53.8% from its June peak. The market and consensus have both priced in a 2027 revenue plateau, setting a low bar, while second-wave customer growth is underrepresented in consensus.
Astera Labs delivered a standout Q3, driven by rapid Scorpio switch adoption, now a $1B ARR business and a key growth catalyst. Q3 revenues surged 154% to $585M, with Scorpio estimated to be growing at a 240% CAGR through CY27, validating management's execution. Gross margins appear to be stabilizing at a 72% floor, positioning ALAB for potential margin expansion and operating leverage.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Stocks surged after a political shake-up, but Wall Street analysts were far from unanimous on Thursday. Some household names got slashed while a struggling airline and a solar giant won new fans. Which side of the call are you on?
Benchmark ALAB against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Astera Labs, Inc. Common Stock (ALAB)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $190.71 | $32.69B | 76.10 | 115.13% | 29.64% | 28.03% | — | |
| $141.20 | $123.52B | 49.27 | 42.09% | 27.93% | 16.22% | 0.17% | |
| $113.58 | $5.73B | 14.13 | 5.34% | 20.2% | 19.21% | — | |
| $210.98 | $16.1B | 49.25 | 37.26% | 25.25% | 22.32% | — | |
| $28.17 | $5.25B | 170.93 | 22.77% | 3.07% | 3.18% | — | |
| $38.88 | $1.97B | 80.81 | -11.11% | 18.53% | 4.86% | — |
Astera Labs, Inc. Common Stock (ALAB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Astera Labs, Inc. Common Stock (ALAB) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 4, 2026·SEC
Nov 3, 2026·SEC
Aug 4, 2026·SEC
Get notified when ALAB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Astera Labs, Inc. Common Stock (ALAB) stock FAQ — growth, dividends, profitability & financials explained
Astera Labs, Inc. Common Stock (ALAB) reported $1.56B in revenue over the trailing twelve months. Revenue was $852.5M in fiscal year 2025. That is 967% more than the $79.9M of fiscal year 2022.
Astera Labs, Inc. Common Stock (ALAB) grew revenue by 115.2% over the trailing twelve months, compared with the twelve months before.
Yes. Astera Labs, Inc. Common Stock (ALAB) earned $461.3M in net income over the trailing twelve months (a 29.6% net margin).
Astera Labs, Inc. Common Stock (ALAB) had a return on equity (ROE) of 28.0% over the trailing twelve months. That is well above the market's typical 10-15%.
Astera Labs, Inc. Common Stock (ALAB) generated $344.7M in free cash flow over the trailing twelve months.
